Ivabradine

Amber-G

Brand Name(s):Procoralan

Indication:Postural Tachycardia Syndrome (off-label use)

Rationale:

Considered:Apr-15

Review Date:Apr-20

Comments:
Prescribing for Postural Tachycardia Syndrome is off-label use.

Seek Specialist advice if you have any concerns if asked to prescribe for this indication. Patient Information leaflet is available at: http://medicinesmanagement.doncasterpct.nhs.uk/ in the guidlines section
April 2015
…………………………
MHRA Drug Safety Update: Ivabradine may be associated with the risks of bradycardia, atrial fibrillation, and other cardiovascular risks. Only start ivabradine if the resting heart rate is at least 70 beats per minute. Do not prescribe ivabradine with other medicines that cause bradycardia. Monitor patients regularly for atrial fibrillation and consider stopping ivabradine if there is only limited symptom improvement after 3 months
December 2014
…………………………